FALCO HOLDINGS Co., Ltd. engages in the provision of clinical testing and dispensing pharmacy services. The company is headquartered in Osaka, Osaka-Fu and currently employs 1,062 full-time employees. The firm operates in two business segments. The Clinical Testing segment is engaged in the contracted clinical specimen testing business for hospitals and clinics, as well as the development and sale of electronic medical charts and other medical information systems, and the wholesale of in-vitro diagnostic drugs. The Dispensing Pharmacy segment is engaged in the operation of dispensing pharmacies.
Based on comprehensive analyst evaluations, we have synthesized critical insights from expert assessments to outline a cautious outlook for FALHF. Analysts note deteriorating fundamentals and challenging market sentiment, indicating potential downside risks in the near term. Following this expert analysis, we adopt a bearish stance on this stock. Our conclusion: FALHF is a Sell candidate.
FALHF stock price ended at $0 on 木曜日, after dropping NaN%
On the latest trading day Feb 12, 2026, the stock price of FALHF fell by NaN%, dropping from $NaN to $NaN. During the session, the stock saw a volatility of NaN%, with prices oscillating between a daily low of $NaN and a high of $NaN. On the latest trading day, the trading volume for FALHF decreased by -- shares, aligning with the declining prices, which may indicate weakening market confidence in the near term. In total, -- shares were traded, with a market value of approximately --.